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Selenocysteine (Sec) is found in active sites of several oxidoreductases in which this residue is essential for catalytic
activity. However, many selenoproteins have fully functional orthologs, wherein cysteine (Cys) occupies the position of
Sec. The reason why some enzymes evolve into selenoproteins if the Cys versions may be sufficient is not understood.
Among three mammalian methionine-R-sulfoxide reductases (MsrBs), MsrB1 is a Sec-containing protein, whereas
MsrB2 and MsrB3 contain Cys in the active site, making these enzymes an excellent system for addressing the question
of why Sec is used in biological systems. In this study, we found that residues, which are uniquely conserved in Cys-
containing MsrBs and which are critical for enzyme activity in MsrB2 and MsrB3, were not required for MsrB1, but
increased the activity of its Cys mutant. Conversely, selenoprotein MsrB1 had a unique resolving Cys reversibly
engaged in the selenenylsulfide bond. However, this Cys was not necessary for activities of either MsrB2, MsrB3, or the
Cys mutant of MsrB1. We prepared Sec-containing forms of MsrB2 and MsrB3 and found that they were more than 100-
fold more active than the natural Cys forms. However, these selenoproteins could not be reduced by the physiological
electron donor, thioredoxin. Yet, insertion of the resolving Cys, which was conserved in MsrB1, into the selenoprotein
form of MsrB3 restored the thioredoxin-dependent activity of this enzyme. These data revealed differences in catalytic
mechanisms between selenoprotein MsrB1 and non-selenoproteins MsrB2 and MsrB3, and identified catalytic
advantages and disadvantages of Sec- and Cys-containing proteins. The data also suggested that Sec- and Cys-
containing oxidoreductases require distinct sets of active-site features that maximize their catalytic efficiencies and
provide strategies for protein design with improved catalytic properties.
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Introduction
Several oxidoreductases, such as glutathione peroxidase,
thioredoxin (Trx) reductase, and methionine sulfoxide (Met-
SO) reductase, have selenocysteine (Sec) in their active sites
[1–3]. These selenoproteins are typically 100- to 1,000-fold
more active than their cysteine (Cys) mutants. This high
catalytic activity of Sec-containing enzymes has been re-
garded as a key reason why Sec is used in biological systems
[4–7]. However, some selenoproteins have orthologs, in which
Cys is used in place of Sec, and which are as catalytically
competent as selenoproteins [8].
Met-SO reductases catalyze the reduction of free and
protein-bound Met-SO back to methionine in the presence of
Trx (reviewed in [9]). There are two distinct classes of Met-SO
reductases; MsrA is speciﬁc for the S isomer of Met-SO,
whereas methionine-R-sulfoxide reductase (MsrB) can reduce
only the R form of this compound. Met-SO reduction is
thought to be an important protein-repair pathway that
provides protection against oxidative stress, regulates protein
function, and delays aging (reviewed in [10–13]). Most
organisms from bacteria to humans employ Met-SO reduc-
tion systems to repair oxidized methionine residues. Human
and mouse genomes possess a single MsrA and three MsrB
genes that code for MsrB1, MsrB2, and MsrB3 (reviewed in
[14]). Among the three mammalian MsrBs, MsrB1 (also known
as selenoprotein R or X) has Sec in its active site [3,15],
whereas MsrB2 (also known as CBS-1) and MsrB3 contain Cys
in place of Sec [16–18]. The three MsrBs are present in
different cellular compartments. MsrB1 is in the cytosol and
nucleus, MsrB2 is in the mitochondria, and MsrB3 is either in
the endoplasmic reticulum or in the mitochondria depending
on alternatively spliced forms and on the organism in which
it occurs [18,19].
A recent study by Gromer et al. addressed the question of
why Sec is used in Trx reductases [8]. These authors showed
that serine (Ser) residues that ﬂank the catalytic Cys–Cys
motif at the C-terminus of the protein provide necessary
adjustments that make a non-selenoprotein Drosophila Trx
reductase as active as its mammalian selenoprotein counter-
parts. This study suggested that Sec is not necessarily
required for efﬁcient catalysis by Trx reductases. However,
the selenoenzymes provide advantages in terms of a broader
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onmental conditions in the active sites.
We previously expressed, in Escherichia coli, a recombinant
selenoprotein form of MsrB1, which has four mutant residues
(S99R, S100L, K102G, and F103P) [18]. These four mutations
introduced a selenocysteine insertion sequence (SECIS)
element downstream of the Sec-encoding UGA codon. This
recombinant selenoprotein exhibited ;1,000-fold higher
enzyme activity than its Cys counterpart, indicating the
essential role of Sec in this enzyme. However, the activities of
recombinant MsrB2 and MsrB3 were ;200-fold higher than
that of the Cys-containing MsrB1 mutant, and only ;4-fold
lower than that of the recombinant selenoprotein MsrB1.
The fact that mammals have one selenoprotein (MsrB1) and
two Cys-containing homologs (MsrB2 and MsrB3), all with
similar catalytic efﬁciencies, allows these enzymes to be used
to address the question of why Sec is used in biological
systems. In the present study, we performed extensive
mutational analyses to better understand the catalytic
advantages and disadvantages that Sec and Cys provide for
MsrB function. We demonstrated differences in catalytic
mechanisms between selenoprotein MsrB1 and non-seleno-
proteins MsrB2 and MsrB3, and found that Sec- and Cys-
containing enzymes require different sets of features in the
active site to maximize their activities.
Results/Discussion
Three Residues Conserved in Cys-Containing MsrBs but
Absent in Selenoprotein MsrB1
Multiple-sequence alignment of available MsrB sequences
revealed three highly conserved residues, which are present
in most MsrBs, but are absent in selenoprotein MsrB1
sequences (Figure 1A). The ﬁrst residue corresponded to
Gly77 in mouse MsrB1 (hereinafter, numbering of amino
acids is based on the MsrB1 sequence, unless noted other-
wise). This residue was replaced with His in all Cys-containing
MsrBs including mammalian MsrB2 and MsrB3. The second
residue was Glu81 in selenoprotein MsrB1. All other MsrBs
had Val or Ile in its place. The third residue was Phe97 in
MsrB1. This residue was replaced with Asn in Cys-containing
MsrBs. MsrBs have a wide distribution, but Sec-containing
MsrBs are present only in vertebrates and co-occur in these
organisms with Cys-containing MsrBs, consistent with recent
evolution of the selenoprotein forms from animal Cys-
containing MsrBs. This sequence analysis (Figure 1) raised
questions as to why the selenoprotein MsrB1 has different
residues at the three positions highly conserved in Cys-
containing enzymes and what the roles of these residues are
in the catalytic function of selenoprotein and non-seleno-
protein MsrBs.
Different Sets of Active-Site Features in Sec-Containing
MsrB1 and Cys-Containing MsrB2 and MsrB3
A crystal structure of an MsrB domain of Neisseria
gonorrhoeae PilB has been reported [20]. This domain
corresponds to a Cys-containing MsrB. pKa values of Cys
thiols are typically around 8.3, unless adjusted by micro-
environmental conditions, whereas the selenol group of Sec is
fully ionized at physiological pH owing to its low pKa value of
5.2 [4,5]. The N. gonorrhoeae MsrB structure suggested that the
catalytic Cys95 nucleophile is activated by a Cys95–Arg93–
Asp85 triad [20] (Figure 1B), which is conserved in all MsrBs
except for replacement of Asp with Glu in some homologs. It
was also proposed, based on the N. gonorrhoeae MsrB structure,
that His77 and Asn97 form hydrogen bonds with a water
molecule, which in turn interacts with the oxygen atom of the
sulfoxide moiety of the substrate [20] (Figure 2). This
hydrogen-bond network may stabilize the intermediate in
Figure 1. Conserved Features in MsrB Sequences and Structures
(A) Alignment of MsrB sequences corresponding to the active sites in
these proteins. Catalytic Cys (C) and Sec (U) residues are shown in red.
The conserved His, Val/Ile, and Asn residues in Cys-containing proteins
are indicated in green, whereas the corresponding residues (Gly, Glu, and
Phe, respectively) in selenoprotein MsrB1 are highlighted in yellow. Gray
shows other conserved residues. Numbering of amino acids is shown
above the sequences and is based on the mouse MsrB1 sequence.
(B) Structure of the active site of N. gonorrhoeae MsrB domain (1L1D). For
convenience, some active-site residues are not shown. Numbering of
amino acids is based on the mouse MsrB1 sequence. The Cys41 is the
resolving Cys. It is absent in all mammalian MsrBs.
(C) Alignment of mouse and human MsrB sequences. Catalytic Cys (C)
and Sec (U) residues are shown in red. Pink indicates Ser and Thr residues
that replace the conserved resolving Cys residues in many MsrB proteins.
Zinc-coordinating Cys residues are shown in yellow. Other conserved Cys
residues in each mouse and human MsrB sequence are indicated in
green, whereas non-conserved Cys residues are shown in gray. Residues
corresponding to Cys4 in MsrB1 are highlighted in turquoise.
DOI: 10.1371/journal.pbio.0030375.g001
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Different Catalytic Mechanisms in MsrBsthe reaction [20]. Thus, the residues conserved in the Cys-
containing MsrBs, but absent in selenoprotein MsrBs (see
Figure 1), are part of the active site.
To further examine the location and function of active-site
residues (Figure 1C), we developed molecular models of
mouse MsrB1, mouse MsrB2, and human MsrB3 (Figure S1).
The locations of the three residues conserved in Cys-
containing MsrBs were similar to those in N. gonorrhoeae MsrB
(Figure 1B). Therefore, we initially hypothesized that His77,
Val/Ile81, and Asn97 in Cys-containing enzymes assist the
catalytic Cys by stabilizing the thiolate, whereas Sec in the
selenoenzyme MsrB1 would not need the assistance of these
residues owing to its high reactivity and low pKa.
Impairment of Selenoprotein MsrB1 Activity by the
Residues Conserved in Cys-Containing MsrBs
To test the roles of these three residues in catalysis by
selenoprotein MsrB1, we expressed a C-terminal His-tagged
Sec-containing MsrB1 in mammalian cells from a construct
containing a natural SECIS element in the 39-untranslated
region, and puriﬁed the protein by afﬁnity chromatography.
We also made a series of mutant constructs in which Gly77,
Glu81, and Phe97 were mutated, individually or in combina-
tion, to His, Val, and Asn, respectively. The proteins were
then assayed for dithiothreitol (DTT)- and Trx-dependent
Met-SO reduction. If Sec did not require assistance from the
residues which are speciﬁc for Cys-containing MsrBs, the
single, double, or triple mutations involving G77H, E81V, and
F97N would not be able to stimulate MsrB1 activity. Indeed,
we found that single G77H, E81V, and F97N mutants
exhibited 9-, 121-, and 26-fold lower activity, respectively,
than the wild-type form in the DTT-dependent reaction
(Table 1). The double G77H/G97N mutant had 15-fold lower
activity than the wild-type enzyme, and the triple G77H/E81V/
F97N mutant was completely inactive. The effects of these
mutations on the Trx-dependent activity were even more
severe (Table 1). Thus, the three residues conserved in Cys-
containing MsrBs were not required for activity of the
selenoprotein MsrB1 form and, in fact, were detrimental to
its enzymatic function.
Increased Activity of the Cys Mutant of MsrB1 by
Introducing Residues Conserved in Cys-Containing MsrBs
We examined the effects of mutations of Gly77, Glu81, and
Phe97 on the catalytic activity of the Cys mutant of MsrB1
(MsrB1-Cys; i.e., Cys95 in place of Sec95). As shown in Table
1, the speciﬁc activity of the G77H version of MsrB1-Cys was
similar to that of the original MsrB1-Cys in both DTT- and
Trx-dependent reactions. However, the replacement of
Phe97 with Asn (F97N mutant) increased the enzyme activity
by 1.5-fold in both assays. Moreover, the double G77H/F97N
Figure 2. Schematic Representation of the Reaction Mechanism of N.
gonorrhoeae MsrB
Numbering of amino acids is based on the mouse MsrB1 sequence. A
water molecule is indicated as W. This reaction mechanism was adapted
from Lowther et al. [20]. The nucleophilic attack by Cys95 on sulfoxide
moiety of the substrate results in a trigonal-bipyramidal intermediate (Ia),
followed by the formation of the sulfenic acid intermediate of Cys95 and
the release of methionine (Ib). The resolving Cys41 attacks the sulfenic
acid intermediate of Cys95 to form a disulfide bond (II). The disulfide
bond is then reduced by Trx in vivo or by DTT in vitro and the active site
is returned to the fully reduced state (III).
DOI: 10.1371/journal.pbio.0030375.g002
Table 1. Specific Activity and Kinetic Constants of Wild-Type and Mutant Forms of Mouse MsrB1
Proteins Forms Specific Activity (nmol/min/mg Protein) Km (mM) kcat (min
 1)
DTT-Dependent Reaction Trx-Dependent Reaction
Sec-containing MsrB1 WT 170 6 26 45 6 11 0.5 6 0.1 13.4 6 2.3
G77H 18 6 5 2.5 6 0.5 0.8 6 0.05 2.6 6 0.8
E81V 1.4 6 0.5 ND NA NA
F97N 6.5 6 2.5 0.3 6 0.1 4.3 6 1.6 0.6 6 0.2
G77H/F97N 11 6 3.7 0.6 6 0.1 6.4 6 2.1 2.4 6 0.5
G77H/E81V/F97N ND ND ND ND
MsrB1-Cys WT 2.0 6 0.2 0.046 6 0.005 1.3 6 0.2 0.11 6 0.03
G77H 1.9 6 0.2 0.055 6 0.004 0.7 6 0.2 0.10 6 0.04
E81V 0.8 6 0.1 0.016 6 0.004 1.0 6 0.1 0.04 6 0.01
F97N 2.9 6 0.1 0.069 6 0.007 7.4 6 1.5 0.64 6 0.15
G77H/F97N 4.9 6 0.1 0.235 6 0.012 13.2 6 2.4 1.38 6 0.30
G77H/E81V/F97N 1.8 6 0.2 0.075 6 0.010 9.1 6 1.3 0.97 6 0.10
Enzyme activity was determined using dabsyl-Met-R-SO as substrate. Substrate concentrations were 250 lM in DTT- and 10 lM in Trx-dependent reactions. Km and kcat values were determined in the presence of DTT. For determination of Km,
0.1–1.0 mM substrate was used. The proteins derived from Sec-containing MsrB1 were purified from transfected NIH 3T3 cells, and those derived from MsrB1-Cys were purified from E. coli.
NA, not assayed; ND, not detected; WT, wild-type.
DOI: 10.1371/journal.pbio.0030375.t001
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Different Catalytic Mechanisms in MsrBsmutant exhibited 2.5- and 5-fold higher activity in DTT- and
Trx-dependent reactions, respectively, than MsrB1-Cys, in-
dicating that these two residues synergistically increased
enzyme activity. The kcat values of F97N and G77H/F97N
mutants were 6- and 13-fold higher, respectively, compared
to that of MsrB1-Cys. Similar to the proposed role for His77
and Asn97 in the hydrogen-bond network in the active site of
N. gonorrhoeae MsrB, these mutations (G77H and F97N) may
have generated a hydrogen-bond network in the active site of
MsrB1-Cys to assist the catalytic function of Cys95. Thus, the
effects of G77H and F97N mutations in MsrB1-Cys are clearly
in contrast to those observed in Sec-containing MsrB1. The
third mutation, E81V, in contrast to expectations, decreased
the MsrB1-Cys activity by 2.5-fold, and it also decreased the
activity of the triple mutant (G77H/E81V/F97N) by 3-fold
compared to the activity of the double mutant (G77H/F97N).
Requirement of Residues Uniquely Conserved in Cys-
Containing MsrBs for Catalytic Activity of These Enzymes
To investigate the roles of the three conserved residues in
catalysis by Cys-containing MsrBs, we mutated these amino
acids in mouse MsrB2 and human MsrB3 to those found in
MsrB1. Table 2 summarizes speciﬁc activities of wild-type and
various mutants of these enzymes. The V81E mutant of MsrB2
showed a 2-fold lower activity than the wild-type protein, and
the activity of the H77G mutant was decreased 50-fold. The
N97F mutation had the most dramatic effect, as activity of this
protein was decreased 7.7 310
3-fold in the presence of DTT,
and was not detectable in the Trx-dependent reaction.
Corresponding mutations in MsrB3 had similar effects (Table
2). Taken together, the data suggest that any changes in
residues uniquely conserved in Cys-containing MsrBs to those
presentinselenoproteinMsrBresultedinlowcatalyticactivity.
Among these residues, Asn had the most dramatic effect.
As discussed above, Asn likely participates in the hydrogen-
bond network and is involved in binding of the substrate or
intermediate in the reaction (see Figure 2). It is possible that
substitution of Asn with Phe (as in MsrB1) disrupts this
network. To test this idea further, we generated mutants of
both MsrB2 and MsrB3 in which Asn was replaced by Tyr.
This mutation increased the enzyme activity 10-fold com-
pared to the Phe mutants. However, the Tyr mutants of
MsrB2 and MsrB3 still exhibited 500- to 800-fold lower
activity than the wild-type proteins. In our structural models
of MsrB2 and MsrB3, Asn is located on the bottom of the
catalytic pocket (Figure S1A). Thus, it is possible that
substitution of Asn with a bulky aromatic amino acid, Phe,
might not only disrupt the hydrogen-bond network in the
active site but might also interfere with the accessibility of the
substrate to the active site.
We determined Km values of wild-type and mutant forms of
all three MsrBs in the DTT-dependent reaction (see Tables 1
and 2). Km values for dabsyl-Met-R-SO were 0.5 mM and 0.8
mM for the wild-type MsrB1 and the corresponding G77H
mutant, respectively. Km values for F97N and G77H/F97N
mutants (4.3 and 6.4 mM, respectively) were signiﬁcantly
increased. Km values for G77H and E81V forms of MsrB1-Cys
(0.7 and 1.0 mM, respectively) were similar to that for the
wild-type MsrB1-Cys (1.3 mM). In contrast, Km values for
F97N, G77H/F97N, and G77H/E81V/F97N mutants were much
higher (6- to 10-fold) than that for MsrB1-Cys. These data,
along with the observation of the increased activity of the
F97N mutant, suggest that the F97N mutation increased the
enzyme activity of MsrB1-Cys at higher concentrations of the
substrate. Km values for wild-type MsrB2 and MsrB3 were 0.31
and 0.8 mM, respectively. Several mutations, including H77G
in MsrB2 and H77G or N97Y in MsrB3, did not change Km
values signiﬁcantly. However, the V81E mutation in MsrB2,
and the I81E mutation in MsrB3, lowered Km values 2- and 4-
fold, respectively.
Increased Activity of Selenoprotein Forms of MsrB2 and
MsrB3 Compared with the Natural Cys-Containing
Enzymes in the DTT-Dependent Reaction
To further address the role of Sec in MsrBs, we developed a
selenoprotein form of MsrB3. To prepare this protein, we
Table 2. Specific Activities and Kinetic Constants of Wild-Type and Mutant Forms of Mouse MsrB2 and Human MsrB3
Proteins Forms Specific Activity (nmol/min/mg Protein) Km (mM) kcat (min
 1)
DTT-Dependent Reaction Trx-Dependent Reaction
MsrB2 WT 386 6 42 10.0 6 1.2 0.31 6 0.10 27.5 6 3.8
H77G 8 6 20 . 2 6 0.03 0.34 6 0.06 0.5 6 0.1
V81E 203 6 26 4.5 6 0.3 0.14 6 0.04 5.6 6 0.7
N97F 0.05 6 0.01 ND ND ND
N97Y 0.47 6 0.03 ND ND ND
H77G/N97F ND ND ND ND
H77G/V81E/N97F ND ND ND ND
MsrB3 WT 452 6 43 23.1 6 3.0 0.8 6 0.05 49.6 6 4.2
H77G 15 6 30 . 3 6 0.02 1.0 6 0.2 1.7 6 0.3
I81E 283 6 38 14.4 6 0.9 0.2 6 0.05 4.2 6 0.5
N97F 0.07 6 0.01 ND ND ND
N97Y 0.86 6 0.05 0.004 6 0.001 1.2 6 0.1 0.02 6 0.01
H77G/N97F ND ND ND ND
H77G/I81E/N97F ND ND ND ND
Concentration of dabsyl-Met-R-SO was 250 lM in DTT-dependent and 10 lM in Trx-dependent reactions. Recombinant proteins purified from E. coli were used. Km and kcat values were determined in the presence of DTT. For determination of
Km of MsrB2, 0.05–0.25 mM substrate was used, whereas 0.1–1.0 mM substrate was used in the case of MsrB3.
ND, not detected; WT, wild-type.
DOI: 10.1371/journal.pbio.0030375.t002
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Different Catalytic Mechanisms in MsrBsinserted a SECIS element of mouse MsrB1 downstream of the
stop codon, replaced the Cys95 codon with TGA, and
introduced a His tag at the C-terminus for afﬁnity isolation
(seleno-MsrB3/C95U construct). We also generated single
N97F and triple H77G/I81E/N97F mutant forms of seleno-
MsrB3/C95U. The constructs were transfected into NIH 3T3
cells, and the seleno-MsrB3 proteins were puriﬁed from these
cells by afﬁnity chromatography. Remarkably, seleno-MsrB3/
C95U had a 126-fold higher activity compared to the wild-type
protein in the DTT-dependent reaction (Table 3). The fact
that a simple mutation of the catalytic Cys to Sec could
improve the enzyme activity so dramatically over that of the
natural enzyme argues foran inherent catalytic advantage that
may be provided by Sec over Cys in certain oxidoreductases.
Further experiments revealed that neither single N97F nor
triple H77G/I81E/N97F mutants of seleno-MsrB3/C95U were
active, indicating that Asn97 was critical for the MsrB3
activity even in the selenoprotein form. As discussed above, it
is possible that the presence of Phe97 in these mutants
blocked the access of the substrate to the active site.
We similarly prepared the selenoprotein form of MsrB2.
This protein, seleno-MsrB2/C95U, showed a 173-fold higher
activity than the natural Cys-containing form in the DTT-
dependent reaction (Table 3). The fact that substitution of
Cys with Sec in MsrB2 and MsrB3 increased MsrB catalytic
activity so markedly is in contrast to the observation that the
activity of the Sec mutant of Drosophila Trx reductase did not
change signiﬁcantly compared to that of the natural Cys-
containing protein [8].
Taken together, our data revealed that (i) His77 and Asn97
are required in Cys-containing MsrBs, and that these residues
could even increase the activity of the MsrB1-Cys mutant; (ii)
Gly77, Glu81, and Phe97 are required in selenoprotein
MsrB1; and (iii) Sec per se could increase the activity of
Cys-containing MsrBs.
Difference in Trx Dependency between Selenoprotein and
Non-Selenoprotein MsrBs
The reaction mechanism of MsrA is well understood [21–
25]. It has been proposed that the catalytic mechanism of
MsrBs from Drosophila melanogaster, N. gonorrhoeae, and N.
meningitides [20,26–28] is similar to that of MsrA, even though
MsrA and MsrB are structurally unrelated enzymes [20,22–
24,29]. The previously proposed reaction mechanism of MsrB
includes three steps (Figure 2): (i) an attack by the catalytic
Cys on the sulfoxide moiety of the substrate with the
formation of a sulfenic acid intermediate and the concom-
itant release of methionine; (ii) formation of an intra-
molecular disulﬁde bond between catalytic and resolving
Cys residues; and (iii) reduction of the disulﬁde by Trx, a
natural electron donor, or by DTT (which can serve as
reductant in in vitro assays). DTT could also directly reduce
the sulfenic acid intermediate.
Multiple-sequence alignment revealed that the resolving
Cys41 (see Figure 1B) is conserved in only ;60% of known
MsrBs. The remaining ;40% of MsrBs, including all three
mammalian MsrBs, do not have this resolving Cys (Figure 1C).
In addition, Mycoplasma pulmonis and Vibrio cholerae MsrBs have
only a single Cys in their sequences, and several enzymes
including that from Mesorhizobium loti have only a single Cys
besides zinc-coordinating Cys residues. Two possible alter-
native reaction mechanisms can be postulated for MsrBs that
lack the conserved resolving Cys, including (i) a direct
reduction of the sulfenic acid intermediate by Trx (or other
electron donors); and (ii) the use of an alternative resolving
Cys to generate the intramolecular disulﬁde. The latter
mechanism has been reported in a recent study [30], which
identiﬁed an alternative resolving Cys in Xanthomonas
campestris MsrB. However, this Cys is absent in mammalian
MsrBs. We also analyzed mammalian MsrB1, MsrB2, and
MsrB3 by gel ﬁltration and found that these enzymes were
monomeric (data not shown). Therefore, the reversible
intermolecular disulﬁde or selenenylsulﬁde bond is not likely
in these proteins.
As shown in Figure 1C, mouse MsrB1 contains six Cys
residues (Cys4, Cys23, Cys26, Cys58, Cys71, and Cys74). Four
of these residues (Cys23, Cys26, Cys71, and Cys74) are
organized in two CxxC motifs and are involved in zinc
coordination [26]. Cys58 is not conserved in several other
mammalian MsrB1s, including human MsrB1.
Based on these observations, we hypothesized that the only
remaining Cys in MsrB1, Cys4 (Figure 1C), is a candidate
resolving residue that forms an intramolecular selenenylsul-
ﬁde bond with the catalytic Sec95. To test this idea, we
mutated this residue to Ser in both Sec-containing MsrB1 and
MsrB1-Cys, and determined catalytic activities of the C4S
mutants and corresponding wild-type enzymes in DTT- and
Trx-dependent reactions. This mutation did not change the
DTT-dependent activity of the selenoprotein (Figure 3).
However, in the presence of Trx, the C4S mutant was
inactive. On the other hand, the C4S version of MsrB1-Cys
had activity similar to that of MsrB1-Cys in both DTT- and
Trx-dependent reactions. Thus, Cys4 was required for the
Trx-recycling process of the selenoprotein, but was not
needed in the presence of DTT or for the Cys form of the
enzyme.
We further tested the ability of the selenoprotein forms of
MsrB2 and MsrB3 to catalyze Met-SO reduction in the
presence of Trx. In contrast to the ﬁnding that these
selenoproteins exhibited .100-fold increased activity in the
presence of DTT compared to the natural Cys forms, these
proteins were not active in the Trx-dependent assay (Table 3).
Table 3. Specific Activities of Wild-Type and Selenoprotein
Forms of MsrB3 and MsrB2
Proteins Forms Specific Activity
(nmol/min/mg Protein)
DTT-Dependent
Reaction
Trx-Dependent
Reaction
MsrB3 WT 41 6 13 3.2 6 0.6
C95U 5,158 6 565 ND
C95U/N97F ND ND
C95U/H77G/I81E/N97F ND ND
C95U/S41C 4,427 6 320 ND
C95U/T4C 320 6 47 3.6 6 0.5
MsrB2 WT 4 6 1.5 1.3 6 0.2
C95U 692 6 124 ND
C95U/T4C 12 6 4N D
All proteins including wild-type Cys forms were purified from transfected NIH 3T3 cells. For determination of MsrB3
activity, dabsyl-Met-R-SO concentration was 200 lM in DTT- and 10 lM in Trx-dependent reactions. In the MsrB2
enzyme assay, 5 lM substrate was used in both DTT- and Trx-dependent reactions.
ND, not detected; WT, wild-type.
DOI: 10.1371/journal.pbio.0030375.t003
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intermediate in natural or unnatural selenoprotein MsrBs
could form a selenenylsulﬁde bond with the resolving Cys,
which could then be reduced by Trx. However, in the absence
of the resolving Cys, the selenenic acid intermediate could
not be reduced by Trx, but was reducible by DTT. In fact,
although the distance between Sec95 and Cys4 was calculated
to be ;10 A ˚ in the MsrB1 structural model, the selenenyl-
sulﬁde-bond formation should be possible because of
ﬂexibility of the N-terminal region of protein, which includes
a hinge consisting of Gly8 and Gly9 (Figure S1B). In contrast,
a sulfenic acid intermediate in Cys-containing MsrBs could
either form a disulﬁde bond or be directly reduced by Trx or
DTT.
To test this possibility, two questions should be addressed.
First, are there any resolving Cys residues in MsrB2 or MsrB3?
Second, if no resolving Cys residues are present in these
proteins, is it feasible to introduce an artiﬁcial resolving Cys,
which could assist the selenoprotein forms of MsrB2 or
MsrB3? To address the ﬁrst question, we tested two Cys
residues located in the N-terminal region (the only non-
catalytic and non-zinc-binding Cys residues in MsrB3
sequences) for a possible role of a resolving Cys in MsrB3.
These CysA and CysB residues correspond to positions 35 and
41, respectively, in the human MsrB3 sequence (highlighted in
green in Figure 1C). These residues were mutated to Ser to
generate single or double mutants. As shown in Figure 4, in
the DTT assay, all single and double Cys!Ser mutants
exhibited activities similar to that of the wild-type enzyme. In
addition, all mutants were active in the Trx assay (even
though the mutations decreased enzyme activities), suggesting
that the resolving Cys was not required for MsrB3 function.
To answer the second question (concerning the introduc-
tion of an artiﬁcial resolving Cys in the selenoprotein forms
of MsrB2 or MsrB3), we analyzed structural models and the
multiple-sequence alignment (see Figure 1C) and selected
two candidate sites for insertion of the candidate resolving
Cys: (i) Ser41 in MsrB3 (Thr41 in MsrB2), which corresponds
to the resolving Cys present in 60% of MsrBs; and (ii) Thr4 in
MsrB3 and MsrB2, which corresponds to Cys4 in MsrB1.
Separately, we mutated these residues to Cys in the seleno-
MsrB3/C95U form and isolated proteins following large-scale
transfections of NIH 3T3 cells. The activity of the S41C
selenoprotein MsrB3 was slightly lower than that of the
seleno-MsrB3/C95U in the presence of DTT (Table 3).
However, this mutant had no activity in the Trx assay, as
observed above for seleno-MsrB3/C95U. Although the T4C
mutation decreased the MsrB activity 16-fold in the DTT-
dependent reaction (compared to seleno-MsrB3/C95U), the
T4C mutant form of this selenoprotein exhibited signiﬁcant
activity in the presence of Trx, which was as high as the
activity of the natural Cys-containing form. Thus, the
catalytic Sec/resolving Cys pair introduced into MsrB3 could
fully replace the catalytic Cys in the Trx-dependent reaction.
Since this effect was observed in the context of the active-site
environment adapted for the Cys-containing enzyme, it is
possible that this enzyme could be further improved by
additional mutations in the active site (or by natural
selection). These observations have direct implications for
the possibility of improving catalytic properties of oxidor-
eductases containing catalytic Cys residues.
To test the effects of these mutations on the activity of the
natural Cys-containing MsrB3, we generated S41C and T4C
mutants of this protein in E. coli (see Figure 4). Both S41C and
T4C mutations signiﬁcantly decreased the enzyme activity. We
Figure 4. Relative Activity of Various Mutant Forms of MsrB3
Activities of the indicated mutants were normalized to those found in
the wild-type form in both Trx-dependent (black bars) and DTT-
dependent (gray bars) assays. Concentration of the substrate (dabsyl-
Met-R-SO) was 200 lM in the DTT assay and 10 lM in the Trx assay.
Proteins purified from E. coli were used. CysA and CysB correspond to
positions 35 and 41, respectively, in the human MsrB3 sequence.
DOI: 10.1371/journal.pbio.0030375.g004
Figure 3. Cys4 Is Required for Trx-Dependent Reduction of Sec-
Containing MsrB1
Catalytic activities of C4S mutant forms of selenoprotein MsrB1 (shown
as MsrB1-Sec in the figure) and MsrB1-Cys are shown as compared to the
activities of the corresponding proteins containing natural Cys4. Dabsyl-
Met-R-SO substrate concentration was 250 lM in DTT- and 10 lM in Trx-
dependent reactions. Sec-containing MsrB1 and its C4S mutant forms
were purified from transfected NIH 3T3 cells, whereas MsrB1-Cys and its
C4S mutant were obtained from E. coli. No activity of the C4S mutant of
Sec-containing MsrB1 was detected in the Trx-dependent reaction.
DOI: 10.1371/journal.pbio.0030375.g003
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Different Catalytic Mechanisms in MsrBsalso generated and assayed a T4C mutant of seleno-MsrB2/
C95U (Table 3). The activity of this mutant in DTT assays was
decreased 58-fold compared to that of seleno-MsrB2/C95U,
and the mutant was not active in the presence of Trx.
Taken together, our data suggest that different catalytic
mechanisms are employed by selenoprotein and non-seleno-
protein forms of mammalian MsrBs, with the key difference
being the reduction of proteins by Trx. As shown in Figure 5,
a selenenic acid intermediate of selenoprotein MsrB1 could
form a selenenylsulﬁde bond with the resolving Cys4.
Subsequently, the selenenylsulﬁde is reduced by Trx. The
selenenic acid intermediate itself, however, is not reducible
by Trx. In contrast, the resolving Cys may be dispensable for
Cys-containing MsrB2 and MsrB3, in which the sulfenic acid
intermediate could be directly reduced by Trx. At least in
MsrB3, introduction of the catalytic Sec/resolving Cys pair
could change the reaction mechanism from that of Cys-
containing mammalian MsrBs to that of MsrB1.
Catalytic Advantages and Disadvantages of Sec-
Containing Proteins Compared to Cys-Containing
Counterparts
In a broader context, our data provide insights into
catalytic advantages and disadvantages of Sec-containing
proteins compared to their Cys-containing counterparts. It
appears that Sec per se may often result in a higher catalytic
activity, as illustrated in our study by a dramatic increase in
the DTT-dependent reduction of Met-SO by Sec-containing
MsrB2 and MsrB3 compared to their natural Cys-containing
forms. It has previously been reported that the activity of a
plant phospholipid hydroperoxide glutathione peroxidase is
enhanced by simply replacing the active-site Cys with Sec [31].
However, the replacement of Cys with Sec may not only affect
activity and substrate speciﬁcity, but may also completely
change protein function. For example, a Sec-containing form
of subtilisin became an efﬁcient peroxidase rather than a
protease [32]. The use of Sec in glutathione S-transferase also
converted this protein into a peroxidase [33].
Selenoproteins typically are better catalysts than their Cys-
containing orthologs. For example, the activity of Sec-
containing formate dehydrogenases is much higher than that
of the natural Cys-containing enzymes [34]. Thus, the
enhanced activity of selenoproteins compared to their Cys-
containing counterparts is an obvious advantage of Sec over
Cys in certain types of protein function and is likely a reason
why Sec evolves from Cys in proteins.
Does selenium play a role in increasing the catalytic activity
of MsrBs only? We found that selenoprotein MsrB1 exhibited
;2.5-fold lower activity than MsrB2 and MsrB3 in the
presence of DTT (see Tables 1 and 2). However, in the Trx
assay, the speciﬁc activity of selenoprotein MsrB1 was 4.5-
and 2.0-fold higher than those of MsrB2 and MsrB3,
respectively. Therefore, these data suggest that selenoprotein
MsrB1 is a better substrate for Trx than Cys-containing
MsrB2 and MsrB3.
Our data also identiﬁed catalytic disadvantages provided by
Sec. Although the Met-SO reduction was increased more than
100-fold in the Sec-containing forms of MsrB2 and MsrB3,
the regeneration of the active enzymes by the natural
electron donor, Trx, was not possible. Some of our attempts
to develop a highly active enzyme that could be reduced with
Trx by introducing a resolving Cys did not succeed. However,
the T4C form of Sec-containing MsrB3 was fully active (its
activity was equal to that of the natural Cys-containing
enzyme) in the Trx-dependent reaction. We propose that in
MsrBs the use of Sec is a compromise between elevated rates
of Met-SO reduction and the ability to regenerate the active
enzyme form by reduction with the natural electron donor.
The regeneration of the Cys-containing proteins posed no
problems as the sulfenic acid intermediate could be directly
reduced by either DTT or Trx. It is possible that the reason
why the insertion (at a place normally observed in Cys-
containing MsrBs) of the resolving Cys in selenoprotein forms
of MsrB2 and MsrB3 did not support regeneration of these
proteins with Trx was a highly negative redox potential of the
selenenylsulﬁde bond compared to the disulﬁde present in
Cys-containing proteins. Selenenylsulﬁde is known to have a
low redox potential [35]. Diselenide has an even lower redox
potential, probably explaining why this group has never been
observed in selenoenzymes.
Evolutionary and Protein-Design Implications
As discussed above, it is highly likely that the selenoprotein
MsrB1 evolved by the replacement of Cys with Sec. The
conserved Thr4, which is identical in all non-selenoproteins,
would have been concomitantly changed to Cys, which made
the selenoprotein active in the Trx-dependent reaction. The
conserved residues in the active site, such as His77, Val/Ile81,
and Asn97 could then be replaced with Gly77, Glu81, and
Phe97 to maximize enzyme activity.
The full advantages of Sec in proteins are probably not
fully utilized because evolution of Sec is a difﬁcult process.
Not only must a Cys codon be changed to TGA (Sec codon),
but the genes must evolve SECIS elements. At least in
bacteria, where SECIS elements are located in coding regions,
constraints imposed by protein sequence might not always be
compatible with the evolution of a highly speciﬁc stem-loop
structure of the SECIS element. In addition, Sec may evolve
only in organisms which already have the Sec insertion system
(approximately a quarter of all organisms) and only in
environments where increased dependence on the trace
element selenium may be satisﬁed. It is highly likely that the
replacement of catalytic redox-active Cys with Sec in proteins
Figure 5. Models for Catalytic Mechanisms of Mammalian MsrB Enzymes
In MsrB1 (upper part of the figure), the catalytic Sec directly attacks the
Met-SO substrate. A resulting selenenic acid intermediate of selenopro-
tein MsrB1, which is not reducible by Trx, then forms a selenenylsulfide
bond with resolving Cys4. Subsequently, the selenenylsulfide is reduced
by Trx. In contrast, a sulfenic acid intermediate of MsrB2 and MsrB3
(lower part of the figure) can be directly reduced by Trx, making the
resolving Cys dispensable.
DOI: 10.1371/journal.pbio.0030375.g005
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widespread.
Thus, evolution of Sec-containing proteins is a complex
process, in which enhanced catalytic efﬁciency provided by
Sec is in balance with limitations imposed by electron donors
(or acceptors depending on the reaction), dependence on
selenium, and the availability of the Sec insertion system.
It should be possible to apply these concepts to increase the
catalytic efﬁciencies of various redox enzymes. Candidate
strategies include direct replacement of catalytic Cys with Sec,
as well as concomitant design of a resolving Cys and active-
site environment. Enzymes containing catalytic redox-active
Cys should be the best targets in order to design proteins with
improved catalytic properties. For example, peroxiredoxins
are viewed as important antioxidant proteins, but their Trx-
dependent peroxidase activities are low compared to the
activities of selenoprotein peroxidases, such as mammalian
glutathione peroxidase. It is possible that selenoprotein
peroxiredoxins, which are adapted for the use of catalytic
Sec, will be superior catalysts. In fact, genes encoding
bacterial Sec-containing peroxiredoxins have been detected.
In conclusion, this study shows the ﬁrst evidence that the
catalytic mechanism of selenoprotein MsrB differs from that
of mammalian Cys-containing homologs with respect to the
dependence on the unique resolving Cys and on the natural
electron donor, and suggests that Sec- and Cys-containing
proteins require a different set of active-site features that
maximize their catalytic efﬁciencies. Based on these data, we
propose that Sec per se may increase the catalytic efﬁciency
of many oxidoreductases that utilize catalytic redox-active
thiols, but the overall effect of having catalytic Sec should be
viewed in the context of limitations that come with it.
Materials and Methods
Cloning, expression, and puriﬁcation of wild-type and mutant
forms of mouse MsrB1. An 810-bp cDNA for mouse MsrB1 including
a3 9-untranslated region that contains the SECIS element [3] was
cloned into XhoI/NotI sites of pCI-neo (Promega, Madison, Wisconsin,
United States) to generate a construct that codes for the full-length
Sec-containing MsrB1. In addition, we introduced ﬁve His residues at
the C-terminus, which already had a C-terminal His. The resulting
construct was named pCI-SelR-His. Through site-directed muta-
genesis using QuickChange Site-Directed Mutagenesis Kit (Strata-
gene, La Jolla, California, United States), several constructs encoding
various mutant MsrB1 forms with the C-terminal His tag were
generated using pCI-SelR-His as template. All constructs were
veriﬁed by DNA sequencing.
To express wild-type and mutant forms of MsrB1, the constructs
were separately transfected into NIH 3T3 cells using Lipofectamine
and Plus reagents (Invitrogen, Carlsbad, California, United States) on
a large scale. The transfected cells were incubated in Dulbecco’s
modiﬁed Eagle medium containing 10% fetal calf serum, 0.6 lM
sodium selenite, and antibiotics for 2 d at 37 8C under 5% CO2,
collected by scrapping, washed twice with PBS buffer, and resus-
pended in PBS buffer containing 10 mM imidazole and 1 mM
phenylmethylsulfonyl ﬂuoride. Wild-type and mutant forms of MsrB1
were further puriﬁed using Talon metal-afﬁnity resin according to
the manufacturer’s protocol (Clontech, Palo Alto, California, United
States). The eluted proteins were concentrated and dialyzed against
buffer A (50 mM sodium phosphate, pH 7.5, and 50 mM NaCl).
Typical yield of the puriﬁed proteins was 2–7 lg from transfected
cells grown in ten plates (diameter, 100 mm).
Various mutant forms of MsrB1-Cys containing an N-terminal His
tag (MGSSHHHHHHSSGLVPRGSH), except for a C4S mutant, were
generated through site-directed mutagenesis using the MsrB1-Cys
construct [18] made on the basis of pET28a. To avoid possible
interference resulting from the presence of the N-terminal tag close
to the resolving Cys, we generated wild-type and C4S mutant proteins
containing a C-terminal His-tag (LEHHHHHH) as follows. The cDNA
of MsrB1-Cys was cloned into NdeI/XhoI sites of pET21b, resulting in
plasmid pET21-MsrB1-Cys. Then, site-directed mutagenesis was
carried out using the resulting plasmid as template. All constructs
were veriﬁed by DNA sequencing. Wild-type or mutant forms of
MsrB1-Cys were expressed in E. coli BL21(DE3) cells and puriﬁed
using Talon metal-afﬁnity resin (Clontech) as described previously
[18]. The eluted proteins were dialyzed against buffer A, and analyzed
for purity by SDS-PAGE. The enzyme activities of N-terminal and C-
terminal tagged MsrB1-Cys were similar.
Cloning, expression, and puriﬁcation of wild-type and mutant
forms of mouse MsrB2 and human MsrB3. Several constructs
encoding mutant MsrB2 containing a C-terminal His tag
(LEHHHHHH) were prepared through site-directed mutagenesis
using a full-length mouse MsrB2 construct [18] as template. An
MsrB3AD(1–31) construct [18] that lacked the endoplasmic retic-
ulum–targeting sequence was used as template to generate various
mutants of human MsrB3 containing a C-terminal His tag
(LEHHHHHH). All constructs were veriﬁed by DNA sequencing.
The constructs were expressed in E. coli BL21(DE3) cells, puriﬁed
using Talon afﬁnity column (Clontech), and dialyzed against buffer A.
The purity of the puriﬁed proteins was analyzed by SDS-PAGE.
Cloning, expression, and puriﬁcation of selenoprotein forms of
mouse MsrB2 and human MsrB3. A4 5 7 - b pc D N Af r a g m e n t
corresponding to the 39-untranslated region of mouse MsrB1 and
containing the MsrB1 SECIS element was cloned into SalI/NotI sites of
pCI-neo, resulting in plasmid pCI-SECIS. Mouse MsrB2(24–175)
containing a C-terminal His tag (LEHHHHHH) and lacking the
mitochondrial signal peptide was cloned into EcoRI/SalI of pCI-SECIS
to generate a wild-type construct, pCI-B2WT. A pCI-B2WT-Sec
construct, which codes for a selenoprotein form of MsrB2, was
generated by mutating the Cys162 codon (this position is based on
the MsrB2 sequence) to the Sec codon, UGA. Other mutants of the
selenoprotein MsrB2 form were made using pCI-B2WT-Sec as
template by site-directed mutagenesis. Human MsrB3(32–192) con-
taining a C-terminal His tag (LEHHHHHH) and lacking the
endoplasmic reticulum signal was cloned into EcoRI/SalI of pCI-
SECIS to generate a wild-type construct, pCI-B3WT. To prepare a
pCI-B3WT-Sec construct coding for a selenoprotein of MsrB3, a
Cys158 codon (this position is based on the MsrB3 sequence) was
replaced with a Sec codon, UGA. Other mutant forms of MsrB3
selenoprotein were made using pCI-B3WT-Sec as template by site-
directed mutagenesis.
To express recombinant selenoprotein forms of MsrB2 and MsrB3,
each of the constructs was separately transfected into NIH 3T3 cells
on a large scale. For comparison, the constructs encoding Cys forms
of proteins (pCI-B2WT or pCI-B3WT) were separately expressed in
NIH 3T3 cells (see Table 3). Procedures for expression and
puriﬁcation of proteins were as described above for Sec-containing
MsrB1.
Determination of protein concentration. For all puriﬁed proteins
expressed in E. coli, protein concentration was determined by the
Bradford method using bovine serum albumin as a standard. Because
of small amounts of the afﬁnity-puriﬁed proteins expressed in NIH
3T3 cells, the protein concentration was determined by Western
blotting with isozyme-speciﬁc antibodies using bacterially expressed
recombinant MsrB1-Cys, full-length MsrB2, or MsrB3(32–192), as
internal standards, followed by quantitation of the Western blot
signals with a densitometer.
Determination of MsrB activity and analysis of enzyme kinetics.
MsrB activity was assayed in the presence of DTT or Trx. Dabsylated
Met-R-SO was used as substrate. Catalytic activities of MsrBs with
DTT were higher than with Trx. Different concentrations of the
substrate in DTT- and Trx-dependent reactions were chosen to
optimize the enzyme assays. In the DTT-dependent reaction, a typical
reaction mixture (100 ll) for reduction of dabsyl-Met-R-SO to dabsyl-
Met contained 50 mM sodium phosphate, pH 7.5, 50 mM NaCl, 20
mM DTT, 200 or 250 lM Met-R-SO, and puriﬁed proteins. In the Trx-
dependent reaction, a typical reaction mixture (100 ll) contained 50
mM sodium phosphate, pH 7.5, 50 mM NaCl, 6.8 lM E. coli Trx
(Sigma), 0.2 mM NADPH, 0.4 lM E. coli Trx reductase (Sigma), 10 lM
substrate, and puriﬁed proteins. The reactions were carried out at 37
8C for 30–60 min and were then stopped by adding 200 llo f
acetonitrile. The reaction product, dabsyl-Met, was analyzed by HPLC
as described previously [26]. Km and kcat values were determined for
the DTT-dependent reaction from Lineweaver-Burk plots.
It should be noted that the MsrB3 form expressed in E. coli
exhibited an 11-fold higher activity than the proteins puriﬁed from
NIH 3T3 cells. The reasons for this difference are not known. To
avoid these variables, the proteins (including all controls) used in
each experiment were prepared in the same expression system.
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Different Catalytic Mechanisms in MsrBsGel ﬁltration. Apparent molecular masses of MsrB proteins were
determined by gel ﬁltration using a TSK-GEL G3000PWXL column
(internal diameter 0.78 3 30 cm, Tosoh Bioscience, http://www.
tosohbioscience.com). The recombinant proteins puriﬁed from E. coli
were loaded onto the column and eluted with PBS buffer. The full-
length MsrB1-Cys, full-length MsrB2, and MsrB3(32–192), were found
to migrate as monomers.
Molecular modeling. Structural models of mouse MsrB1 (residues 1
to 116), mouse MsrB2 (residues 36 to 175), and human MsrB3
(residues 42 to 184) were built using a crystal structure of the N.
gonorrhoeae MsrB domain (PDB 1L1D) as template with 3D-JIGSAW
(http://www.bmm.icnet.uk/servers/3djigsaw) [36] and SWISS-MODEL
(http://swissmodel.expasy.org) [37], and the constructed models were
e v a l u a t e dw i t hP R O C H E C K( h t t p : / / www.biochem.ucl.ac.uk/bsm/
biocomp) in CCP4 [38]. The modeled structures were visualized with
PyMOL [39].
Supporting Information
Figure S1. Structural Models of Mammalian MsrBs
(A) Surface models of mouse MsrB2 and human MsrB3. Catalytic
Cys95 residues are shown in red. Asn97 residues that sit at the bottom
of the active-site pockets inMsrB2 and MsrB3 are shown in blue.
(B) Mouse MsrB1. In the structural model, the distance between Cys4
and Sec95 was ;10 A ˚ . A hinge consisting of Gly8 and Gly9 is shown in
blue and indicated by arrows. Four Cys residues that coordinate Zn
are shown in orange (the zinc atom is not shown).
Found at DOI: 10.1371/journal.pbio.0030375.sg001 (1.3 MB PDF).
Accession Numbers
The GenBank (http://www.ncbi.nlm.nih.gov/Genbank) identiﬁcation
numbers for MsrB1, MsrB2, and MsrB3 sequences utilized in the study
are 7305478, 27753987, and 72534836, respectively. The GenBank
accession number for D. melanogaster Trx reductase is 10953878 and
for N. gonorrhoeae PilB is 19526685. GenBank accession numbers for
the amino acid sequences of MsrBs shown in Figure 1 (but not already
listed above) are Agrobacterium tumefaciens (5888246), Arabidopsis
thaliana (4115939), D. melanogaster (17944415), E. coli (15802192),
Helicobacter pylori (3252888), Hemophilus inﬂuenzae (16273361), Homo
sapiens MsrB1 (45439350), H. sapiens MsrB2 (20149599), Methanother-
mobacter thermautotrophicus (15678738), Mus musculus MsrB3 (15396336
and 31342784), Mycobacterium tuberculosis (15609811), Saccharomyces
cerevisiae (6319816), Salmonella enterica (16760604), and V. cholerae
(15642000).
Acknowledgments
We thank Hideaki Moriyama for help with modeling of MsrB
structures and Dan Su and Dolph Hatﬁeld for reading the manu-
script. This study was supported by National Institutes of Health
AG021518 and GM061603 (to VNG).
Competing interests. The authors have declared that no competing
interests exist.
Author contributions. HYK and VNG conceived and designed the
experiments. HYK performed the experiments. HYK and VNG
analyzed the data and wrote the paper. &
References
1. Chambers I, Frampton J, Goldfarb P, Affara N, McBain W, et al. (1986) The
structure of the mouse glutathione peroxidase gene: The selenocysteine in
the active site is encoded by the ‘‘termination’’ codon, TGA. EMBO J 5:
1221–1227.
2. Gladyshev VN, Jeang KT, Stadtman TC (1996) Selenocysteine, identiﬁed as
the penultimate C-terminal residue in human T-cell thioredoxin reductase,
corresponds to TGA in the human placental gene. Proc Natl Acad Sci U S A
93: 6146–6151.
3. Kryukov GV, Kumar RA, Koc A, Sun Z, Gladyshev VN (2002) Selenoprotein
R is a zinc-containing stereo-speciﬁc methionine sulfoxide reductase. Proc
Natl Acad Sci U S A 99: 4245–4250.
4. Jacob C, Giles GI, Giles NM, Sies H (2003) Sulfur and selenium: The role of
oxidation state in protein structure and function. Angew Chem Int Ed 42:
4742–4758.
5. Stadtman TC (1996) Selenocysteine. Annu Rev Biochem 65: 83–100.
6. Hatﬁeld DL, Gladyshev VN (2002) How selenium has altered our under-
standing of the genetic code. Mol Cell Biol 22: 3565–3576.
7. Bock A, Forchhammer K, Heider J, Baron C (1991) Selenoprotein synthesis:
An expansion of the genetic code. Trends Biochem Sci 16: 463–467.
8. Gromer S, Johansson L, Bauer, H, Arscott, LD, Rauch, S, et al. (2003) Active
sites of thioredoxin reductases: Why selenoproteins? Proc Natl Acad Sci U
S A 100: 12618–12623.
9. Weissbach H, Etienne F, Hoshi T, Heinemann SH, Lowther WT, et al. (2002)
Peptide methionine sulfoxide reductase: Structure, mechanism of action,
and biological function. Arch Biochem Biophys 397: 172–178.
10. Weissbach H, Resnick L, Brot N (2005) Methionine sulfoxide reductases:
History and cellular role in protecting against oxidative damage. Biochim
Biophys Acta 1703: 203–212.
11. Petropoulos I, Friguet B (2005) Protein maintenance in aging and
replicative senescence: A role for the peptide methionine sulfoxide
reductases. Biochim Biophys Acta 1703: 261–266.
12. Stadtman ER, Van Remmen H, Richardson A, Wehr NB, Levine RL (2005)
Methionine oxidation and aging. Biochim Biophys Acta 1703: 135–140.
13. Moskovitz J (2005) Methionine sulfoxide reductases: Ubiquitous enzymes
involved in antioxidant defense, protein regulation, and prevention of
aging-associated diseases. Biochim Biophys Acta 1703: 213–219.
14. Hansel A, Heinemann SH, Hoshi T (2005) Heterogeneity and function of
mammalian MSRs: Enzymes for repair, protection and regulation. Biochim
Biophys Acta 1703: 239–247.
15. Lescure A, Gautheret D, Carbon P, Krol A (1999) Novel selenoproteins
identiﬁed in silico and in vivo by using a conserved RNA structural motif. J
Biol Chem 274: 38147–38154.
16. Huang W, Escribano J, Sarfarazi M, Coca-Prados M (1999) Identiﬁcation,
expression and chromosome localization of a human gene encoding a novel
protein with similarity to the pilB family of transcriptional factors (pilin)
and to bacterial peptide methionine sulfoxide reductases. Gene 233: 233–
240.
17. Jung S, Hansel A, Kasperczyk H, Hoshi T, Heinemann SH (2002) Activity,
tissue distribution and site-directed mutagenesis of a human peptide
methionine sulfoxide reductase of type B: hCBS1. FEBS Lett 527: 91–94.
18. Kim HY, Gladyshev VN (2004) Methionine sulfoxide reduction in mammals:
Characterization of methionine-R-sulfoxide reductases. Mol Biol Cell 15:
1055–1064.
19. Kim HY, Gladyshev VN (2004) Characterization of mouse endoplasmic
reticulum methionine-R-sulfoxide reductase. Biochem Biophys Res Com-
mun 320: 1277–1283.
20. Lowther WT, Weissbach H, Etienne F, Brot N, Matthews BW (2002) The
mirrored methionine sulfoxide reductases of Neisseria gonorrhoeae pilB. Nat
Struct Biol 9: 348–352.
21. Lowther WT, Brot N, Weissbach H, Honek JF, Matthews BW (2000) Thiol-
disulﬁde exchange is involved in the catalytic mechanism of peptide
methionine sulfoxide reductase. Proc Natl Acad Sci U S A 97: 6463–6468.
22. Lowther WT, Brot N, Weissbach H, Matthews BW (2000) Structure and
mechanism of peptide methionine sulfoxide reductase, an ‘‘anti-oxidation’’
enzyme. Biochemistry 39: 13307–13312.
23. Tete-Favier F, Cobessi D, Boschi-Muller S, Azza S, Branlant G, et al. (2000)
Crystal structure of the Escherichia coli peptide methionine sulphoxide
reductase at 1.9 A ˚ resolution. Structure Fold Des 8: 1167–1178.
24. Taylor AB, Benglis DM Jr, Dhandayuthapani S, Hart PJ (2003) Structure of
Mycobacterium tuberculosis methionine sulfoxide reductase A in complex with
protein-bound methionine. J Bacteriol 185: 4119–4126.
25. Antoine M, Boschi-Muller S, Branlant G (2003) Kinetic characterization of
the chemical steps involved in the catalytic mechanism of methionine
sulfoxide reductase A from Neisseria meningitides. J Biol Chem 278: 45352–
45357.
26. Kumar RA, Koc A, Cerny RL, Gladyshev VN (2002) . Kumar RA, Koc A,
Cerny RL, Gladyshev VN (2002) Reaction mechanism, evolutionary analysis,
and role of zinc in Drosophila methionine-R-sulfoxide reductase, J Biol
Chem 277: 37527–37535.
27. Olry A, Boschi-Muller S, Marraud M, Sanglier-Cianferani S, Van Dorsselear
A, et al. (2002) Characterization of the methionine sulfoxide reductase
activities of PILB, a probable virulence factor from Neisseria meningitidis.J
Biol Chem 277: 12016–12022.
28. Olry A, Boschi-Muller S, Branlant G (2004) Kinetic characterization of the
catalytic mechanism of methionine sulfoxide reductase B from Neisseria
meningitidis. Biochemistry 43: 11616–11622.
29. Kauffmann B, Aubry A, Favier F (2005) The three-dimensional structures of
peptide methionine sulfoxide reductases: Current knowledge and open
questions. Biochim Biophys Acta 1703: 249–260.
30. Neiers F, Kriznik A, Boschi-Muller S, Branlant G (2004) Evidence for a new
sub-class of methionine sulfoxide reductases B with an alternative
thioredoxin recognition signature. J Biol Chem 279: 42462–42468.
31. Hazebrouck S, Camoin L, Faltin Z, Strosberg AD, Eshdat Y (2000)
Substituting selenocysteine for catalytic cysteine 41 enhances enzymatic
activity of plant phospholipid hydroperoxide glutathione peroxidase
expressed in Escherichia coli. J Biol Chem 275: 28715–28721.
32. Bell IM, Fisher ML, Wu ZP, Hilvert D. (1993) Kinetic studies on the
peroxidase activity of selenosubtilisin. Biochemistry 32: 3754–3762.
33. Yu HJ, Liu JQ, Bock A, Li J, Luo GM, et al. (2005) Engineering glutathione
transferase to a novel glutathione peroxidase mimic with high catalytic
efﬁciency. Incorporation of selenocysteine into a glutathione-binding
PLoS Biology | www.plosbiology.org December 2005 | Volume 3 | Issue 12 | e375 2088
Different Catalytic Mechanisms in MsrBsscaffold using an auxotrophic expression system. J Biol Chem 280: 11930–
11935.
34. Axley MJ, Bock A, Stadtman TC (1991) Catalytic properties of an Escherichia
coli formate dehydrogenase mutant in which sulfur replaces selenium. Proc
Natl Acad Sci U S A 88: 8450–8454.
35. Besse D, Siedler F, Diercks T, Kessler H, Moroder L (1997) The redox
potential of selenocystine in unconstrained cyclic peptides. Angew Chem
Int Ed 36: 883–885.
36. Bates PA, Kelley LA, MacCallum RM, Sternberg MJ (2001) Enhancement of
protein modeling by human intervention in applying the automatic
programs 3D-JIGSAW and 3D-PSSM. Proteins 45: 39–46.
37. Schwede T, Kopp J, Guex N, Peitsch MC (2003) SWISS-MODEL: An
automated protein homology-modeling server. Nucleic Acids Res 31: 3381–
3385.
38. Collaborative Computational Project (1994) The CCP4 Suite: Programs for
protein crystallography. Acta Crystallogr D Biol Crystallogr 50: 760–763.
39. DeLano WL (2002) The PyMOL Molecular Graphics System [computer
program]. San Carlos (California): DeLano Scientiﬁc
PLoS Biology | www.plosbiology.org December 2005 | Volume 3 | Issue 12 | e375 2089
Different Catalytic Mechanisms in MsrBs